EFFECT OF LARGE ORAL DOSES OF VITAMIN E ON THE NEUROLOGICAL SEQUELAE OF PATIENTS WITH ABETALIPOPROTEINEMIA
- 1 September 1982
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 393 (1), 133-144
- https://doi.org/10.1111/j.1749-6632.1982.tb31239.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- ASSOCIATION OF SPINOCEREBELLAR DISORDERS WITH CYSTIC FIBROSIS OR CHRONIC CHILDHOOD CHOLESTASIS AND VERY LOW SERUM VITAMIN EThe Lancet, 1981
- Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein.JCI Insight, 1981
- A Progressive Neurologic Syndrome in Children with Chronic Liver DiseaseNew England Journal of Medicine, 1981
- The neuropathy of abetalipoproteinemiaNeurology, 1980
- Reversibility of human myopathy caused by vitamin E deficiencyNeurology, 1979
- ABETALIPOPROTEINEMIA TREATED WITH PARENTERAL AND ORAL VITAMINS A AND E, AND WITH MEDIUM CHAIN TRIGLYCERIDESActa Paediatrica, 1978
- Long-term management of abetalipoproteinaemia. Possible role for vitamin E.Archives of Disease in Childhood, 1977
- Turnover of apolipoprotein-B in two subjects with familial hypobetalipoproteinemiaMetabolism, 1977
- The relative importance of the factors involved in the absorption of vitamin E in childrenGut, 1974
- ON HAVING NO BETA-LIPOPROTEIN A SYNDROME COMPRISING A-BETA-LIPOPROTEINÆMIA, ACANTHOCYTOSIS, AND STEATORRHŒAThe Lancet, 1960